AZ513 is a reversible FAAH inhibitor with an IC 50 s of 551 nM and 27 nM for human FAAH and rat FAAH , respectively. AZ513 inhibits Anandamide ( HY-10863 ) hydrolysis in human FAAH-transfected HEK293 cells (IC 50 of 360 nM).
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > FAAH
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.